Sang Mi Hyun

Title: Sang Mi Hyun: Innovator in Nanoparticle Toxicity Diagnosis

Introduction

Sang Mi Hyun is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of nanoparticle toxicity diagnosis. Her innovative work focuses on developing biomarkers that can effectively evaluate the toxicity of nanoparticles, which is crucial for health and safety assessments.

Latest Patents

Sang Mi Hyun holds a patent titled "Biomarker for diagnosing toxicity of nanoparticles and method for evaluating toxicity of nanoparticles using the same." This patent discloses a biomarker composition that shows a change in expression when exposed to nanoparticles. The composition includes at least one gene selected from a specific group, which correlates highly with nanoparticle toxicity. The method she developed allows for high detection sensitivity in determining whether nanoparticles are toxic. This innovation is essential for monitoring and evaluating the health effects of nanoparticles.

Career Highlights

Sang Mi Hyun is affiliated with the Ajou University Industry-Academic Cooperation Foundation. Her work at this institution emphasizes the importance of research and collaboration in advancing scientific knowledge. She has dedicated her career to understanding the implications of nanoparticles on health and safety.

Collaborations

Sang Mi Hyun has collaborated with notable colleagues, including Woo Young Shim and Duc Toan Nguyen. These partnerships have enhanced her research efforts and contributed to the development of effective diagnostic tools.

Conclusion

Sang Mi Hyun's innovative work in nanoparticle toxicity diagnosis represents a significant advancement in the field. Her contributions are vital for ensuring safety in the use of nanoparticles in various applications.